Cormedix Inc (CRMD)
5.255
-0.16
(-3.04%)
USD |
NASDAQ |
Apr 19, 16:00
5.21
-0.04
(-0.86%)
After-Hours: 20:00
Cormedix Enterprise Value: 221.97M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 221.97M |
| April 17, 2024 | 223.07M |
| April 16, 2024 | 221.42M |
| April 15, 2024 | 219.77M |
| April 12, 2024 | 245.06M |
| April 11, 2024 | 275.30M |
| April 10, 2024 | 214.27M |
| April 09, 2024 | 185.13M |
| April 08, 2024 | 185.68M |
| April 05, 2024 | 182.93M |
| April 04, 2024 | 169.19M |
| April 03, 2024 | 151.04M |
| April 02, 2024 | 148.29M |
| April 01, 2024 | 153.24M |
| March 28, 2024 | 157.09M |
| March 27, 2024 | 152.69M |
| March 26, 2024 | 149.94M |
| March 25, 2024 | 148.29M |
| March 22, 2024 | 139.50M |
| March 21, 2024 | 138.40M |
| March 20, 2024 | 132.90M |
| March 19, 2024 | 134.55M |
| March 18, 2024 | 132.90M |
| March 15, 2024 | 133.45M |
| March 14, 2024 | 153.79M |
| Date | Value |
|---|---|
| March 13, 2024 | 138.40M |
| March 12, 2024 | 112.00M |
| March 11, 2024 | 117.50M |
| March 08, 2024 | 126.30M |
| March 07, 2024 | 123.00M |
| March 06, 2024 | 121.20M |
| March 05, 2024 | 119.00M |
| March 04, 2024 | 117.90M |
| March 01, 2024 | 125.59M |
| February 29, 2024 | 118.45M |
| February 28, 2024 | 118.45M |
| February 27, 2024 | 117.90M |
| February 26, 2024 | 105.82M |
| February 23, 2024 | 104.17M |
| February 22, 2024 | 101.97M |
| February 21, 2024 | 102.52M |
| February 20, 2024 | 104.72M |
| February 16, 2024 | 105.82M |
| February 15, 2024 | 103.62M |
| February 14, 2024 | 99.77M |
| February 13, 2024 | 93.18M |
| February 12, 2024 | 104.72M |
| February 09, 2024 | 98.67M |
| February 08, 2024 | 89.88M |
| February 07, 2024 | 85.49M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
33.06M
Minimum
Mar 18 2020
543.60M
Maximum
Feb 19 2021
142.33M
Average
129.59M
Median
Jan 17 2023
Enterprise Value Benchmarks
| BioXcel Therapeutics Inc | 113.35M |
| Assertio Holdings Inc | 36.39M |
| Verastem Inc | 160.84M |
| Ocular Therapeutix Inc | 748.59M |
| PAVmed Inc | 75.16M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.75M |
| Total Expenses (Quarterly) | 15.67M |
| EPS Diluted (Quarterly) | -0.26 |
| Earnings Yield | -17.51% |
| Normalized Earnings Yield | -14.10 |